Exact Mass: 183.0756

Exact Mass Matches: 183.0756

Found 7 metabolites which its exact mass value is equals to given mass value 183.0756, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

2,6-Diamino-4-hydroxy-5-N-methylformamidopyrimidine

N-(2,4-diamino-1,6-dihydro-6-oxo-5-Pyrimidinyl)-N-methyl-formamide

C6H9N5O2 (183.0756)


2,6-Diamino-4-hydroxy-5-N-methylformamidopyrimidine is a methylated derivative of 2,6-Diamino-4-hydroxy-5-N-formamidopyrimidine or FapyGua. It is produced by DNA-formamidopyrimidine glycosylase (EC 3.2.2.23). This enzyme catalyzes the hydrolysis of DNA containing ring-opened 7-methylguanine residues, releasing 2,6-diamino-4-hydroxy-5-(N-methyl)formamidopyrimidine. More specifically, this enzyme catalyzes the removal of oxidized purine bases by cleaving the N-C1 glycosidic bond between the oxidized purine and the deoxyribose sugar. The reaction involves the formation of a covalent enzyme substrate intermediate. Release of the enzyme and free base by a beta-elimination or a beta, gamma-elimination mechanism results in the cleavage of the DNA backbone 3 of the apurinic (AP) site. The presence of this compound in urine is indicative of oxidative damage to DNA (oxidized purine base lesions) [HMDB] 2,6-Diamino-4-hydroxy-5-N-methylformamidopyrimidine is a methylated derivative of 2,6-Diamino-4-hydroxy-5-N-formamidopyrimidine or FapyGua. It is produced by DNA-formamidopyrimidine glycosylase (EC 3.2.2.23). This enzyme catalyzes the hydrolysis of DNA containing ring-opened 7-methylguanine residues, releasing 2,6-diamino-4-hydroxy-5-(N-methyl)formamidopyrimidine. More specifically, this enzyme catalyzes the removal of oxidized purine bases by cleaving the N-C1 glycosidic bond between the oxidized purine and the deoxyribose sugar. The reaction involves the formation of a covalent enzyme substrate intermediate. Release of the enzyme and free base by a beta-elimination or a beta, gamma-elimination mechanism results in the cleavage of the DNA backbone 3 of the apurinic (AP) site. The presence of this compound in urine is indicative of oxidative damage to DNA (oxidized purine base lesions).

   

4-Amino-2-dimethylamino-6-hydroxy-5-nitrosopyrimidine

4-Amino-2-dimethylamino-6-hydroxy-5-nitrosopyrimidine

C6H9N5O2 (183.0756)


   

2,4-Pyrimidinediamine,N2,N4-dimethyl-5-nitro-

2,4-Pyrimidinediamine,N2,N4-dimethyl-5-nitro-

C6H9N5O2 (183.0756)


   

4(1H)-Pteridinone, 2-amino-4a,5,6,7-tetrahydro-4a-hydroxy-, (S)

4(1H)-Pteridinone, 2-amino-4a,5,6,7-tetrahydro-4a-hydroxy-, (S)

C6H9N5O2 (183.0756)


   

1-[(6E)-5-hydroxy-1-methyl-1,6-dihydro-1,2,4-triazin-6-ylidene]-3-methylurea

1-[(6E)-5-hydroxy-1-methyl-1,6-dihydro-1,2,4-triazin-6-ylidene]-3-methylurea

C6H9N5O2 (183.0756)


   

N-(2,4-diamino-6-hydroxypyrimidin-5-yl)-N-methylformamide

N-(2,4-diamino-6-hydroxypyrimidin-5-yl)-N-methylformamide

C6H9N5O2 (183.0756)


   

DiaminohydroxyN-methylformamidopyrimidine

DiaminohydroxyN-methylformamidopyrimidine

C6H9N5O2 (183.0756)